3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
67
Lung Neoplasms
29
Brain Neoplasms
11
Head and Neck Neoplasms
10
Neoplasms
9
Esophageal Neoplasms
9
Breast Neoplasms
8
Adenocarcinoma of Lung
8
Adenocarcinoma Of Esophagus
7
Glioblastoma
6
Gliosarcoma
5
Esophageal Squamous Cell Carcinoma
5
NSCLC
4
Central Nervous System Neoplasms
4
Adenocarcinoma, Bronchiolo-Alveolar
4
Squamous Cell Carcinoma of Head and Neck
3
Rectal Neoplasms
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Neoplasm Metastasis
3
Colorectal Neoplasms
3
Colonic Neoplasms
3
Unspecified Adult Solid Tumor, Protocol Specific
2
Stomach Neoplasms
2
Osteosarcoma
2
Oligodendroglioma
2
Neuroblastoma
2
Lymphoid Interstitial Pneumonia
2
Laryngeal Diseases
2
Glioma
2
Interventions
Gefitinib
1
Erlotinib Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Advanced Stage Non Small Cell Lung Cancer
×
Gefitinib
×
Clear all
NCT01955421
2015-07-03
NSCLC EGFR TKI
Sun Yat-sen University
Phase 2
Unknown
224 enrolled